A new study shows that nine out of every 10 breast cancer patients in Nigeria and Ghana have to pay for their breast cancer diagnostic tests and treatment themselves.
In Kenya, the figure stands at three out of every 10 patient, says the report by Switzerland-based biotech company Roche.
Roche says these delays, coupled with the high cost of treatment, have contributed to high mortality rates across Sub Saharan Africa.
A patient’s chance of survival can be impacted by delays in diagnosis and treatment, limitations in access to appropriate and quality cancer care, and financial burdens associated with receiving care.
Patients also face significant delays and lengthy waiting times for diagnostic tests and treatment.
Waiting times for surgery stands at at least four months.
Breast cancer is the leading cause of cancer-related deaths in women in Nigeria, Ghana and Kenya.
Have your say
More Lifestyle Headlines
- Accra Mall opens applications for maiden Future Fashion Fund
- Ghanaian children depend on only one pediatric cardiologist
- Gov’t launches action plan to tackle pollution
- 7 common fights couples have during the first year of marriage
- The healthy vegetable that can poison your liver
- Lifestyle with Sakwaba: Yes, rice water can do magic to your hair
- Describing women as complex has mental health implications- Psychologist
- Ridge hospital makes impact on the psychological well-being of Ghanaians
- 10 ways to plan a low budget wedding
- Nurse, midwife suspended for unprofessional conduct
- The suicide survivor who was arrested at work
- Take charge of your heart – Head of Cardiology, KATH
- UNFPA, GHS launch ‘Time with Grandma’ to tackle teenage pregnancy
- How to choose love over lust in everyday life
- Joy as Zipline drone delivers medication to 11-year-old sickle cell patient